The use of biodegradable (SX-ELLA) oesophageal stents to treat dysphagia due to benign and malignant oesophageal disease

被引:43
作者
Griffiths, Ewen A. [2 ]
Gregory, Catherine J. [2 ]
Pursnani, Kishore G. [2 ]
Ward, Jeremy B. [2 ]
Stockwell, Robert C. [1 ]
机构
[1] Chorley & S Ribble Hosp, NHS Fdn Trust, Lancashire Teaching Hosp, Dept Radiol, Chorley PR7 1PP, England
[2] Royal Preston Hosp, NHS Fdn Trust, Lancashire Teaching Hosp, Dept Upper Gastrointestinal Surg, Preston PR2 9HT, Lancs, England
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2012年 / 26卷 / 08期
关键词
Oesophageal cancer; Biodegradable stent; Dysphagia; EXPANDABLE METAL STENTS; NEOADJUVANT THERAPY; CLINICAL-TRIAL; STRICTURES; CANCER; STENOSIS; EFFICACY; SAFETY; CHEMOTHERAPY; MANAGEMENT;
D O I
10.1007/s00464-012-2192-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Biodegradable (BD) oesophageal stents have been available commercially only since 2008 and previous published research is limited. Our aim was to review the use of BD stents to treat dysphagia in benign or malignant oesophageal strictures. Patients were identified from a prospective interventional radiological database. BD stents were inserted radiologically under fluoroscopic control. Between July 2008 and February 2011, 25 attempts at placing SX-ELLA biodegradable oesophageal stents were made in 17 males and five females, with a median age of 69 (range = 54-80) years. Two patients required more than one BD stent. Indications were benign strictures (n = 7) and oesophageal cancer (n = 17). One attempt was unsuccessful for a technical success rate of 96% with no immediate complications. Clinical success rate was 76%. Median dysphagia score before stent insertion was 3 (range = 2-4) compared to 2 (range = 0-3) after stent insertion (p = 0.0001). BD stents provide good dysphagia relief for the life time of the stent. They may help avoid the use of feeding tubes in patients having radical chemoradiotherapy or awaiting oesophagectomy. They do not require removal or interfere with radiotherapy planning via imaging. However, the reintervention rate is high after the stent dissolves.
引用
收藏
页码:2367 / 2375
页数:9
相关论文
共 32 条
[1]   Expandable metallic stents should not be used in the treatment of benign esophageal strictures [J].
Ackroyd, R ;
Watson, DI ;
Devitt, PG ;
Jamieson, GG .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (04) :484-487
[2]   Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer [J].
Allum, William H. ;
Stenning, Sally P. ;
Bancewicz, John ;
Clark, Peter I. ;
Langley, Ruth E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) :5062-5067
[3]   Use of a fully covered self-expandable metal stent for the treatment of benign esophageal diseases [J].
Bakken, Johan C. ;
Song, Louis M. Wong Kee ;
de Groen, Piet C. ;
Baron, Todd H. .
GASTROINTESTINAL ENDOSCOPY, 2010, 72 (04) :712-720
[4]   Quality of life and enteral nutrition [J].
Bozzetti, Federico .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2008, 11 (05) :661-665
[5]   A Prospective Phase II Evaluation of Esophageal Stenting for Neoadjuvant Therapy for Esophageal Cancer: Optimal Performance and Surgical Safety [J].
Brown, Russell E. ;
Abbas, Abbas E. ;
Ellis, Susan ;
Williams, Shannon ;
Scoggins, Charles R. ;
McMasters, Kelly M. ;
Martin, Robert C. G., II .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2011, 212 (04) :582-588
[6]   Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis [J].
Burstow, M. ;
Kelly, T. ;
Panchani, S. ;
Khan, I. M. ;
Meek, D. ;
Memon, B. ;
Memon, M. A. .
DISEASES OF THE ESOPHAGUS, 2009, 22 (06) :519-525
[7]   Covered Biodegradable Stent: New Therapeutic Option for the Management of Esophageal Perforation or Anastomotic Leak [J].
Cerna, Marie ;
Koecher, Martin ;
Valek, Vlastimil ;
Aujesky, Rene ;
Neoral, Cestmir ;
Andrasina, Tomas ;
Panek, Jiri ;
Mahathmakanthi, Shankari .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 34 (06) :1267-1271
[8]   Results of expandable metal stents for malignant esophageal obstruction in 100 patients: Short-term and long-term follow-up [J].
Christie, NA ;
Buenaventura, PO ;
Fernando, HC ;
Nguyen, NT ;
Weigel, TL ;
Ferson, PF ;
Luketich, JD .
ANNALS OF THORACIC SURGERY, 2001, 71 (06) :1797-1801
[9]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[10]   A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma [J].
Dallal, HJ ;
Smith, GD ;
Grieve, DC ;
Ghosh, S ;
Penman, ID ;
Palmer, KR .
GASTROINTESTINAL ENDOSCOPY, 2001, 54 (05) :549-557